Home World News EMA Recommends Granting a Marketing Authorisation for Poherdy World News EMA Recommends Granting a Marketing Authorisation for Poherdy By Ogkologos - April 10, 2026 251 0 Facebook Twitter Google+ Pinterest WhatsApp It is a biosimilar of pertuzumab which was authorised in the EU in 2013 Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR 4-Year-Old Secretly Told Teacher His Dad Was Sick, And She Donated... September 4, 2019 New on NCI’s Websites for July 2021 July 13, 2021 DIY Mosquito Traps & Deterrents (That Really Work) June 23, 2021 A Combination of Amivantamab and Lazertinib Shows Durable Clinical Activity in... October 10, 2023 Load more HOT NEWS First Mature Estimation of Median OS for Selpercatinib in Patients with... p53 Mutations May Differentially Affect Survival of Patients with mCRC Based... Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with... Cancer in My Community: How People With Cancer Access Care in...
